SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin

Nature

Volumn 544, Issue 7651, 2017, Pages 493-497

  Chen, Jun ^a   Zhong, Ming Chao ^a   Guo, Huaijian ^a,b   Davidson, Dominique ^a   Mishel, Sabrin ^c,d   Lu, Yan ^a   Rhee, Inmoo ^a,b,e   Pérez Quintero, Luis Alberto ^a,b   Zhang, Shaohua ^a   Cruz Munoz, Mario Ernesto ^a,f   Wu, Ning ^a   Vinh, Donald C ^b,g   Sinha, Meenal ^h   Calderon, Virginie ^a   Lowell, Clifford A ^h   Danska, Jayne S ^c,d   Veillette, André ^a,b,i  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Sejong University   (South Korea)

^f University of Morelos   (Mexico)

^g RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTEGRIN; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE; SLAMF7 PROTEIN; UNCLASSIFIED DRUG; ACTIN; CD47 ANTIGEN; CD47 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; SIRPA PROTEIN, HUMAN; SLAMF7 PROTEIN, HUMAN; SLAMF7 PROTEIN, MOUSE;

CELLS AND CELL COMPONENTS; GENE EXPRESSION; HEMATOLOGY; IMMUNE RESPONSE; INHIBITION; LIGAND; PROTEIN; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; GENE DELETION; GENE LOCUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DEFICIENCY; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; PATHOLOGY;

ACTINS; ANIMALS; ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE FAMILY;

EID: 85018954219     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature22076     Document Type: Article

References (47)

1. Korman, A. J., Peggs, K. S. & Allison, J. P. Checkpoint blockade in cancer immunotherapy. Adv. Immunol. 90, 297-339 (2006).
2. Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205-214 (2015).
3. Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907-917 (2015).
4. Gordon, S., Plüddemann, A. & Martinez Estrada, F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol. Rev. 262, 36-55 (2014).
5. Schultze, J. L. & Schmidt, S. V. Molecular features of macrophage activation. Semin. Immunol. 27, 416-423 (2015).
6. Freeman, S. A. & Grinstein, S. Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol. Rev. 262, 193-215 (2014).
7. Chao, M. P. et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142, 699-713 (2010).
8. Majeti, R. et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138, 286-299 (2009).
9. Jaiswal, S. et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138, 271-285 (2009).
10. Theocharides, A. P. et al. Disruption of SIRP? signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J. Exp. Med. 209, 1883-1899 (2012).
11. Murata, Y., Kotani, T., Ohnishi, H. & Matozaki, T. The CD47-SIRP? signalling system: its physiological roles and therapeutic application. J. Biochem. 155, 335-344 (2014).
12. Barclay, A. N. & Van den Berg, T. K. The interaction between signal regulatory protein alpha (SIRP? ) and CD47: structure, function, and therapeutic target. Annu. Rev. Immunol. 32, 25-50 (2014).
13. Chao, M. P., Weissman, I. L. & Majeti, R. The CD47-SIRP? pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 24, 225-232 (2012).
14. Ho, J. M., Danska, J. S. & Wang, J. C. Targeting SIRP? in cancer. OncoImmunology 2, e23081 (2013).
15. Wu, N. & Veillette, A. SLAM family receptors in normal immunity and immune pathologies. Curr. Opin. Immunol. 38, 45-51 (2016).
16. Cannons, J. L., Tangye, S. G. & Schwartzberg, P. L. SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 29, 665-705 (2011).
17. Calpe, S. et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv. Immunol. 97, 177-250 (2008).
18. ffrench-Constant, C. & Colognato, H. Integrins: versatile integrators of extracellular signals. Trends Cell Biol. 14, 678-686 (2004).
19. Miranti, C. K. & Brugge, J. S. Sensing the environment: a historical perspective on integrin signal transduction. Nat. Cell Biol. 4, E83-E90 (2002).
20. Arnaout, M. A., Mahalingam, B. & Xiong, J. P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381-410 (2005).
21. Jakus, Z., Fodor, S., Abram, C. L., Lowell, C. A. & Mócsai, A. Immunoreceptor-like signaling by ? 2 and ? 3 integrins. Trends Cell Biol. 17, 493-501 (2007).
22. Hamerman, J. A., Ni, M., Killebrew, J. R., Chu, C. L. & Lowell, C. A. The expanding roles of ITAM adapters FcR? and DAP12 in myeloid cells. Immunol. Rev. 232, 42-58 (2009).
23. Chao, M. P. et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2, 63ra94 (2010).
24. Veillette, A. & Guo, H. CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma. Crit. Rev. Oncol. Hematol. 88, 168-177 (2013).
25. Guo, H., Cruz-Munoz, M. E., Wu, N., Robbins, M. & Veillette, A. Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring Src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells. Mol. Cell. Biol. 35, 41-51 (2015).
26. Rawlings, D. J. et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361 (1993).
27. Takai, T., Li, M., Sylvestre, D., Clynes, R. & Ravetch, J. V. FcR ? chain deletion results in pleiotrophic effector cell defects. Cell 76, 519-529 (1994).
28. Todd, R. F. III. The continuing saga of complement receptor type 3 (CR3). J. Clin. Invest. 98, 1-2 (1996).
29. Guo, H. et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J. Exp. Med. 213, 2187-2207 (2016).
30. Wu, N. et al. A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education. Nat. Immunol. 17, 387-396 (2016).
31. Dong, Z. et al. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity 36, 974-985 (2012).
32. Elliott, E. R. et al. Deletion of Syk in neutrophils prevents immune complex arthritis. J. Immunol. 187, 4319-4330 (2011).
33. Kaifu, T. et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111, 323-332 (2003).
34. Mócsai, A. et al. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7, 1326-1333 (2006).
35. Rhee, I., Davidson, D., Souza, C. M., Vacher, J. & Veillette, A. Macrophage fusion is controlled by the cytoplasmic protein tyrosine phosphatase PTP-PEST/ PTPN12. Mol. Cell. Biol. 33, 2458-2469 (2013).
36. Dong, Z. et al. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat. Immunol. 10, 973-980 (2009).
37. Chow, L. M. et al. Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. Oncogene 9, 3437-3448 (1994).
38. Abraham, N., Miceli, M. C., Parnes, J. R. & Veillette, A. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 350, 62-66 (1991).
39. Bouchon, A., Cella, M., Grierson, H. L., Cohen, J. I. & Colonna, M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167, 5517-5521 (2001).
40. Latour, S., Chow, L. M. & Veillette, A. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J. Biol. Chem. 271, 22782-22790 (1996).
41. Cruz-Munoz, M. E., Dong, Z., Shi, X., Zhang, S. & Veillette, A. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat. Immunol. 10, 297-305 (2009).
42. Heit, B. et al. Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization. Dev. Cell 24, 372-383 (2013).
43. Cloutier, P., Lavallée-Adam, M., Faubert, D., Blanchette, M. & Coulombe, B. Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. J. Proteomics 100, 115-124 (2014).
44. Veillette, A., Bookman, M. A., Horak, E. M. & Bolen, J. B. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55, 301-308 (1988).
45. Kohlmann, A. et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. Br. J. Haematol. 142, 802-807 (2008).
46. Bagger, F. O. et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 44 (D1), D917-D924 (2016).
47. Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467-472 (2011).